Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $1.16 in the prior trading day, Gossamer Bio Inc (NASDAQ: GOSS) closed at $1.17, up 0.86%. In other words, the price has increased by $0.86 from its previous closing price. On the day, 1.11 million shares were traded. GOSS stock price reached its highest trading level at $1.22 during the session, while it also had its lowest trading level at $1.13.
Ratios:
Our goal is to gain a better understanding of GOSS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.88 and its Current Ratio is at 6.88. In the meantime, Its Debt-to-Equity ratio is 6.88 whereas as Long-Term Debt/Eq ratio is at 6.85.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on June 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $9.
UBS Downgraded its Buy to Neutral on July 27, 2023, whereas the target price for the stock was revised from $8 to $1.25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 24 ’24 when Aranda Richard sold 1,908 shares for $0.66 per share. The transaction valued at 1,260 led to the insider holds 196,891 shares of the business.
Hasnain Faheem bought 372,000 shares of GOSS for $250,282 on Jun 21 ’24. The President & CEO now owns 5,408,073 shares after completing the transaction at $0.67 per share. On Jun 18 ’24, another insider, Giraudo Bryan, who serves as the COO/CFO of the company, bought 100,000 shares for $0.59 each. As a result, the insider paid 59,110 and bolstered with 480,010 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOSS now has a Market Capitalization of 265848544 and an Enterprise Value of 174212880. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.32 while its Price-to-Book (P/B) ratio in mrq is 8.99. Its current Enterprise Value per Revenue stands at 1.519 whereas that against EBITDA is -2.948.
Stock Price History:
The Beta on a monthly basis for GOSS is 1.88, which has changed by -0.07874018 over the last 52 weeks, in comparison to a change of 0.06429911 over the same period for the S&P500. Over the past 52 weeks, GOSS has reached a high of $1.55, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is -1.44%, while the 200-Day Moving Average is calculated to be 20.84%.
Shares Statistics:
The stock has traded on average 1.45M shares per day over the past 3-months and 1484700 shares per day over the last 10 days, according to various share statistics. A total of 226.60M shares are outstanding, with a floating share count of 182.60M. Insiders hold about 19.64% of the company’s shares, while institutions hold 58.93% stake in the company. Shares short for GOSS as of 1741910400 were 5741046 with a Short Ratio of 3.96, compared to 1739491200 on 5717172. Therefore, it implies a Short% of Shares Outstanding of 5741046 and a Short% of Float of 2.5999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
